Dr. Nichola Conlon
Nichola is the Chief Executive and Co-Founder of Nuchido. Nuchido is focussed on delivering disruptive innovation in the field of anti-ageing, rejuvenation and health-span.
Dr Conlon received her PhD in Physiology from Newcastle University, home to the largest institute for ageing research in Europe. Nichola took her specific expertise in the molecular biology of drug transport and distribution in the body to e-Therapeutics plc, the network pharmacology pioneers, where she worked in early stage drug discovery, specializing in the study of ageing as a biologically complex disorder.
Nichola co-founded Nuchido to bring efficient molecular discovery alongside recent breakthroughs in the science of ageing and rejuvenation. Nuchido is focussed on bringing efficacious anti-ageing products to market, in timescales much shorter that of pharmaceutically regulated products. At Nuchido, she works alongside multiple world-leading scientists including Professors Tom Kirkwood and Thomas von Zglinicki to lead the task of translating these recent scientific breakthroughs into interventions to improve health-span in people, recognizing that, whilst great progress has been made in treating the diseases that ageing potentiates, a focus now must be to reduce the burden of these diseases as we live longer lives.
Increasing NAD+ levels in middle-aged people to a level comparable with people 17 years younger with the data to back it up.